1997
DOI: 10.1016/s0024-3205(97)84299-3
|View full text |Cite
|
Sign up to set email alerts
|

Development of 5-(3-alkenyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine derivatives as selective muscarinic agonists for the treatment of Alzheimer's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2007
2007
2007
2007

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Pyrimidines and their analogues represent an important class of nitrogen heterocycles, which is found in both various biologically active natural compounds and designed medicinal agents . Specifically, tetrahydropyrimidines containing an amino acid unit have attracted much attention due to their interesting and unique properties such as muscarinic agonist activity, protein−nucleic acids interaction, antiviral activity, and inflammatory activity . Structure−activity relationship (SAR) studies of the tetrahydropyrimidine derivatives showed that the substituent groups on the rings are all critical for the activity .…”
mentioning
confidence: 99%
“…Pyrimidines and their analogues represent an important class of nitrogen heterocycles, which is found in both various biologically active natural compounds and designed medicinal agents . Specifically, tetrahydropyrimidines containing an amino acid unit have attracted much attention due to their interesting and unique properties such as muscarinic agonist activity, protein−nucleic acids interaction, antiviral activity, and inflammatory activity . Structure−activity relationship (SAR) studies of the tetrahydropyrimidine derivatives showed that the substituent groups on the rings are all critical for the activity .…”
mentioning
confidence: 99%